ARTICLE | Clinical News
VML 670: Phase I
March 26, 2001 8:00 AM UTC
VER will start Phase I studies of VML 670 in volunteers, and expects to begin Phase IIa studies before year end. VER (formerly Cerebrus Holdings plc) licensed the compound from Eli Lilly and Co. (LLY...